IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide (Q46064600)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide |
scientific article |
Statements
1 reference
IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide (English)
1 reference
1 reference
Karim Maloum
1 reference
Catherine Settegrana
1 reference
Elise Chapiro
1 reference
Bruno Cazin
1 reference
Stéphane Leprêtre
1 reference
Alain Delmer
1 reference
Michel Leporrier
1 reference
Brigitte Dreyfus
1 reference
Olivier Tournilhac
1 reference
Beatrice Mahe
1 reference
Claude Lesty
1 reference
Frederic Davi
1 reference
2 April 2009
1 reference
1 reference
88
1 reference
12
1 reference
1215-1221
1 reference
Identifiers
1 reference
1 reference